These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28276705)

  • 1. Exploring the epigenetic drug discovery landscape.
    Prachayasittikul V; Prathipati P; Pratiwi R; Phanus-Umporn C; Malik AA; Schaduangrat N; Seenprachawong K; Wongchitrat P; Supokawej A; Prachayasittikul V; Wikberg JE; Nantasenamat C
    Expert Opin Drug Discov; 2017 Apr; 12(4):345-362. PubMed ID: 28276705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back.
    Bosia M; Pigoni A; Cavallaro R
    Expert Opin Drug Discov; 2015 Feb; 10(2):125-39. PubMed ID: 25345474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
    Chatterjee P; Roy D; Rathi N
    J Alzheimers Dis; 2018; 61(1):53-65. PubMed ID: 29199645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic prospects for epigenetic modulation.
    Heightman TD
    Expert Opin Ther Targets; 2011 Jun; 15(6):729-40. PubMed ID: 21366500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for the development of epigenetic drugs for CNS conditions.
    Szyf M
    Nat Rev Drug Discov; 2015 Jul; 14(7):461-74. PubMed ID: 26000723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolysis targeting chimeras (PROTACs) for epigenetics research.
    Vogelmann A; Robaa D; Sippl W; Jung M
    Curr Opin Chem Biol; 2020 Aug; 57():8-16. PubMed ID: 32146413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
    Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
    J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving attrition rates in Ebola virus drug discovery.
    Glisic S; Paessler S; Veljkovic N; Perovic VR; Prljic J; Veljkovic V
    Expert Opin Drug Discov; 2015; 10(9):1025-32. PubMed ID: 26125997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-hit wonders: The expanding universe of multitargeting epigenetic agents.
    de Lera AR; Ganesan A
    Curr Opin Chem Biol; 2020 Aug; 57():135-154. PubMed ID: 32784072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson AD; Stegmaier K; Bourdeaut F; Reaman G; Heenen D; Meyers ML; Armstrong SA; Brown P; De Carvalho D; Jabado N; Marshall L; Rivera M; Smith M; Adamson PC; Barone A; Baumann C; Blackman S; Buenger V; Donoghue M; Duncan AD; Fox E; Gadbaw B; Hattersley M; Ho P; Jacobs I; Kelly MJ; Kieran M; Lesa G; Ligas F; Ludwinski D; McDonough J; Nikolova Z; Norga K; Senderowicz A; Taube T; Weiner S; Karres D; Vassal G
    Eur J Cancer; 2020 Nov; 139():135-148. PubMed ID: 32992153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic drug discovery: a success story for cofactor interference.
    Ganesan A
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress on cheminformatics approaches to epigenetic drug discovery.
    Sessions Z; Sánchez-Cruz N; Prieto-Martínez FD; Alves VM; Santos HP; Muratov E; Tropsha A; Medina-Franco JL
    Drug Discov Today; 2020 Dec; 25(12):2268-2276. PubMed ID: 33010481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
    Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
    Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational approaches for innovative antiepileptic drug discovery.
    Talevi A
    Expert Opin Drug Discov; 2016 Oct; 11(10):1001-16. PubMed ID: 27454246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
    Cichonska A; Rousu J; Aittokallio T
    Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The timeline of epigenetic drug discovery: from reality to dreams.
    Ganesan A; Arimondo PB; Rots MG; Jeronimo C; Berdasco M
    Clin Epigenetics; 2019 Dec; 11(1):174. PubMed ID: 31791394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R
    Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery for epigenetics targets.
    Holdgate GA; Bardelle C; Lanne A; Read J; O'Donovan DH; Smith JM; Selmi N; Sheppard R
    Drug Discov Today; 2022 Apr; 27(4):1088-1098. PubMed ID: 34728375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.